Free Trial

Vitalhub (TSE:VHI) Hits New 52-Week High - What's Next?

Vitalhub logo with Medical background

Key Points

  • Vitalhub Corp. reached a new 52-week high of C$14.49, with a trading volume of 260,520 shares, indicating strong investor interest.
  • Several analysts have raised their price targets for Vitalhub, with Scotiabank at C$14.50 and Raymond James at C$14.00, both suggesting an "outperform" rating.
  • The stock has a market capitalization of C$755.13 million and is currently rated as a "Buy" by six investment analysts, with one rating it a "strong buy."
  • Want stock alerts on Vitalhub? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Vitalhub Corp. (TSE:VHI - Get Free Report) reached a new 52-week high during mid-day trading on Friday . The company traded as high as C$14.49 and last traded at C$14.49, with a volume of 260520 shares traded. The stock had previously closed at C$13.59.

Analysts Set New Price Targets

A number of equities analysts have commented on the company. Scotiabank lifted their price target on Vitalhub from C$14.00 to C$14.50 and gave the stock an "outperform" rating in a research note on Friday, June 20th. Raymond James Financial boosted their price objective on shares of Vitalhub from C$13.50 to C$14.00 and gave the company an "outperform" rating in a research report on Friday, June 20th. National Bankshares set a C$14.00 target price on Vitalhub and gave the company an "outperform" rating in a research note on Tuesday, June 10th. Finally, National Bank Financial raised shares of Vitalhub to a "strong-buy" rating in a research note on Monday, June 9th. Six investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Buy" and a consensus price target of C$13.25.

Read Our Latest Research Report on Vitalhub

Vitalhub Price Performance

The stock has a market capitalization of C$755.13 million, a price-to-earnings ratio of 227.05, a price-to-earnings-growth ratio of 1.18 and a beta of 1.26. The firm has a fifty day moving average of C$11.77 and a 200 day moving average of C$10.87.

Insider Buying and Selling at Vitalhub

In related news, Director Francis Nelson Shen purchased 25,000 shares of the firm's stock in a transaction that occurred on Friday, May 16th. The shares were purchased at an average cost of C$10.23 per share, with a total value of C$255,750.00. 18.57% of the stock is currently owned by insiders.

About Vitalhub

(Get Free Report)

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Vitalhub Right Now?

Before you consider Vitalhub, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.

While Vitalhub currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Growth Stocks That Could Pop Before Summer Ends
3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines